APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Niraparib Preparations

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Niraparib Preparations Market Outlook and Growth Opportunities 2026

29 December 2025197 pages

Choose your research edition.

Industry ResearchNiraparib Preparations Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Niraparib Preparations Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Niraparib Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Niraparib Preparations Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Niraparib Preparations Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Niraparib Preparations market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Niraparib Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Niraparib Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Niraparib Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Niraparib Preparations market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Niraparib Preparations market include Zai Lab, Takeda Pharmaceutical, Janssen Biotech and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Niraparib Preparations market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Niraparib Preparations and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Niraparib Preparations sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Niraparib Preparations market size, projected growth trends, production technologies, key applications, and end-use industries.

Niraparib Preparations Segment by Company

Zai Lab

Takeda Pharmaceutical

Janssen Biotech

GSK

Niraparib Preparations Segment by Type

Single Drug

Combination Preparation

Niraparib Preparations Segment by Application

Ovarian Cancer

Prostate Cancer

Primary Peritoneal Cancer

Other

Niraparib Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Niraparib Preparations status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Niraparib Preparations market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Niraparib Preparations significant trends, drivers, influence factors in global and regions.

6. To analyze Niraparib Preparations competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Niraparib Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Niraparib Preparations market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Niraparib Preparations industry.

Chapter 3: Detailed analysis of Niraparib Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Niraparib Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Niraparib Preparations in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Niraparib Preparations Industry Trends Table 2. Niraparib Preparations Industry Drivers Table 3. Niraparib Preparations Industry Opportunities and Challenges Table 4. Niraparib Preparations Industry Restraints Table 5. Global Niraparib Preparations Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Niraparib Preparations Revenue Share by Company (2021-2026) Table 7. Global Niraparib Preparations Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Niraparib Preparations Sales Volume Share by Company (2021-2026) Table 9. Global Niraparib Preparations Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Niraparib Preparations Company Ranking, (2024-2026) & (USD Million) Table 11. Global Niraparib Preparations Key Company Manufacturing Base & Headquarters Table 12. Global Niraparib Preparations Company, Product Type & Application Table 13. Global Niraparib Preparations Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Niraparib Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Drug Table 18. Significant Companies of Combination Preparation Table 19. Global Niraparib Preparations Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Niraparib Preparations Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Niraparib Preparations Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Niraparib Preparations Sales Volume Share by Type (2021-2026) Table 23. Global Niraparib Preparations Sales Volume Share by Type (2027-2032) Table 24. Global Niraparib Preparations Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Niraparib Preparations Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Niraparib Preparations Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Niraparib Preparations Sales Value Share by Type (2021-2026) Table 28. Global Niraparib Preparations Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Ovarian Cancer Table 30. Significant Companies of Prostate Cancer Table 31. Significant Companies of Primary Peritoneal Cancer Table 32. Significant Companies of Other Table 33. Global Niraparib Preparations Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Niraparib Preparations Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Niraparib Preparations Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Niraparib Preparations Sales Volume Share by Application (2021-2026) Table 37. Global Niraparib Preparations Sales Volume Share by Application (2027-2032) Table 38. Global Niraparib Preparations Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Niraparib Preparations Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Niraparib Preparations Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Niraparib Preparations Sales Value Share by Application (2021-2026) Table 42. Global Niraparib Preparations Sales Value Share by Application (2027-2032) Table 43. Global Niraparib Preparations Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Niraparib Preparations Sales by Region (2021-2026) & (K Units) Table 45. Global Niraparib Preparations Sales Market Share by Region (2021-2026) Table 46. Global Niraparib Preparations Sales by Region (2027-2032) & (K Units) Table 47. Global Niraparib Preparations Sales Market Share by Region (2027-2032) Table 48. Global Niraparib Preparations Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Niraparib Preparations Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Niraparib Preparations Sales Value Share by Region (2021-2026) Table 51. Global Niraparib Preparations Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Niraparib Preparations Sales Value Share by Region (2027-2032) Table 53. Global Niraparib Preparations Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Niraparib Preparations Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Niraparib Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Niraparib Preparations Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 58. Global Niraparib Preparations Sales Market Share by Country (2021-2026) Table 59. Global Niraparib Preparations Sales by Country (2027-2032) & (K Units) Table 60. Global Niraparib Preparations Sales Market Share by Country (2027-2032) Table 61. Global Niraparib Preparations Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Niraparib Preparations Sales Value Market Share by Country (2021-2026) Table 63. Global Niraparib Preparations Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Niraparib Preparations Sales Value Market Share by Country (2027-2032) Table 65. Zai Lab Company Information Table 66. Zai Lab Business Overview Table 67. Zai Lab Niraparib Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zai Lab Niraparib Preparations Product Portfolio Table 69. Zai Lab Recent Development Table 70. Takeda Pharmaceutical Company Information Table 71. Takeda Pharmaceutical Business Overview Table 72. Takeda Pharmaceutical Niraparib Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Takeda Pharmaceutical Niraparib Preparations Product Portfolio Table 74. Takeda Pharmaceutical Recent Development Table 75. Janssen Biotech Company Information Table 76. Janssen Biotech Business Overview Table 77. Janssen Biotech Niraparib Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Janssen Biotech Niraparib Preparations Product Portfolio Table 79. Janssen Biotech Recent Development Table 80. GSK Company Information Table 81. GSK Business Overview Table 82. GSK Niraparib Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GSK Niraparib Preparations Product Portfolio Table 84. GSK Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Niraparib Preparations Distributors List Table 88. Niraparib Preparations Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Niraparib Preparations Product Image Figure 2. Global Niraparib Preparations Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Niraparib Preparations Sales Value (2021-2032) & (US$ Million) Figure 4. Global Niraparib Preparations Sales (2021-2032) & (K Units) Figure 5. Global Niraparib Preparations Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Niraparib Preparations Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Drug Image Figure 10. Combination Preparation Image Figure 11. Global Niraparib Preparations Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Niraparib Preparations Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Niraparib Preparations Sales Volume Share by Type (2021-2032) Figure 14. Global Niraparib Preparations Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Niraparib Preparations Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Niraparib Preparations Sales Value Share by Type (2021-2032) Figure 17. Ovarian Cancer Image Figure 18. Prostate Cancer Image Figure 19. Primary Peritoneal Cancer Image Figure 20. Other Image Figure 21. Global Niraparib Preparations Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Niraparib Preparations Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Niraparib Preparations Sales Volume Share by Application (2021-2032) Figure 24. Global Niraparib Preparations Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Niraparib Preparations Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Niraparib Preparations Sales Value Share by Application (2021-2032) Figure 27. Global Niraparib Preparations Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Niraparib Preparations Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Niraparib Preparations Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Niraparib Preparations Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Niraparib Preparations Sales Value (2021-2032) & (US$ Million) Figure 32. North America Niraparib Preparations Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Niraparib Preparations Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Niraparib Preparations Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Niraparib Preparations Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Niraparib Preparations Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Niraparib Preparations Sales Value (2021-2032) & (US$ Million) Figure 38. South America Niraparib Preparations Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Niraparib Preparations Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Niraparib Preparations Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Niraparib Preparations Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Niraparib Preparations Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Niraparib Preparations Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Niraparib Preparations Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Niraparib Preparations Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • Ovarian Cancer
  • Prostate Cancer
  • Primary Peritoneal Cancer
  • Other
Companies covered
  • Zai Lab
  • Takeda Pharmaceutical
  • Janssen Biotech
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Niraparib Preparations Sales Value (2021-2032)
  4. 1.2.2 Global Niraparib Preparations Sales Volume (2021-2032)
  5. 1.2.3 Global Niraparib Preparations Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Niraparib Preparations Market Dynamics
  1. 2.1 Niraparib Preparations Industry Trends
  2. 2.2 Niraparib Preparations Industry Drivers
  3. 2.3 Niraparib Preparations Industry Opportunities and Challenges
  4. 2.4 Niraparib Preparations Industry Restraints
3 Niraparib Preparations Market by Company
  1. 3.1 Global Niraparib Preparations Company Revenue Ranking in 2025
  2. 3.2 Global Niraparib Preparations Revenue by Company (2021-2026)
  3. 3.3 Global Niraparib Preparations Sales Volume by Company (2021-2026)
  4. 3.4 Global Niraparib Preparations Average Price by Company (2021-2026)
  5. 3.5 Global Niraparib Preparations Company Ranking (2024-2026)
  6. 3.6 Global Niraparib Preparations Company Manufacturing Base and Headquarters
  7. 3.7 Global Niraparib Preparations Company Product Type and Application
  8. 3.8 Global Niraparib Preparations Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Niraparib Preparations Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Niraparib Preparations Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Niraparib Preparations Market by Type
  1. 4.1 Niraparib Preparations Type Introduction
  2. 4.1.1 Single Drug
  3. 4.1.2 Combination Preparation
  4. 4.2 Global Niraparib Preparations Sales Volume by Type
  5. 4.2.1 Global Niraparib Preparations Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Niraparib Preparations Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Niraparib Preparations Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Niraparib Preparations Sales Value by Type
  9. 4.3.1 Global Niraparib Preparations Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Niraparib Preparations Sales Value by Type (2021-2032)
  11. 4.3.3 Global Niraparib Preparations Sales Value Share by Type (2021-2032)
5 Niraparib Preparations Market by Application
  1. 5.1 Niraparib Preparations Application Introduction
  2. 5.1.1 Ovarian Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Primary Peritoneal Cancer
  5. 5.1.4 Other
  6. 5.2 Global Niraparib Preparations Sales Volume by Application
  7. 5.2.1 Global Niraparib Preparations Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Niraparib Preparations Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Niraparib Preparations Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Niraparib Preparations Sales Value by Application
  11. 5.3.1 Global Niraparib Preparations Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Niraparib Preparations Sales Value by Application (2021-2032)
  13. 5.3.3 Global Niraparib Preparations Sales Value Share by Application (2021-2032)
6 Niraparib Preparations Regional Sales and Value Analysis
  1. 6.1 Global Niraparib Preparations Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Niraparib Preparations Sales by Region (2021-2032)
  3. 6.2.1 Global Niraparib Preparations Sales by Region: 2021-2026
  4. 6.2.2 Global Niraparib Preparations Sales by Region (2027-2032)
  5. 6.3 Global Niraparib Preparations Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Niraparib Preparations Sales Value by Region (2021-2032)
  7. 6.4.1 Global Niraparib Preparations Sales Value by Region: 2021-2026
  8. 6.4.2 Global Niraparib Preparations Sales Value by Region (2027-2032)
  9. 6.5 Global Niraparib Preparations Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Niraparib Preparations Sales Value (2021-2032)
  12. 6.6.2 North America Niraparib Preparations Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Niraparib Preparations Sales Value (2021-2032)
  15. 6.7.2 Europe Niraparib Preparations Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Niraparib Preparations Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Niraparib Preparations Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Niraparib Preparations Sales Value (2021-2032)
  21. 6.9.2 South America Niraparib Preparations Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Niraparib Preparations Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Niraparib Preparations Sales Value Share by Country, 2025 VS 2032
7 Niraparib Preparations Country-level Sales and Value Analysis
  1. 7.1 Global Niraparib Preparations Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Niraparib Preparations Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Niraparib Preparations Sales by Country (2021-2032)
  4. 7.3.1 Global Niraparib Preparations Sales by Country (2021-2026)
  5. 7.3.2 Global Niraparib Preparations Sales by Country (2027-2032)
  6. 7.4 Global Niraparib Preparations Sales Value by Country (2021-2032)
  7. 7.4.1 Global Niraparib Preparations Sales Value by Country (2021-2026)
  8. 7.4.2 Global Niraparib Preparations Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Niraparib Preparations Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Niraparib Preparations Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Niraparib Preparations Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Niraparib Preparations Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Niraparib Preparations Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Niraparib Preparations Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Niraparib Preparations Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Niraparib Preparations Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Niraparib Preparations Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Niraparib Preparations Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Niraparib Preparations Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Niraparib Preparations Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Niraparib Preparations Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Niraparib Preparations Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Niraparib Preparations Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Niraparib Preparations Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Niraparib Preparations Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Niraparib Preparations Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Niraparib Preparations Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Niraparib Preparations Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Niraparib Preparations Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Niraparib Preparations Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Niraparib Preparations Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Niraparib Preparations Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Niraparib Preparations Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Niraparib Preparations Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Niraparib Preparations Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Niraparib Preparations Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Niraparib Preparations Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Niraparib Preparations Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zai Lab
  2. 8.1.1 Zai Lab Company Information
  3. 8.1.2 Zai Lab Business Overview
  4. 8.1.3 Zai Lab Niraparib Preparations Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zai Lab Niraparib Preparations Product Portfolio
  6. 8.1.5 Zai Lab Recent Developments
  7. 8.2 Takeda Pharmaceutical
  8. 8.2.1 Takeda Pharmaceutical Company Information
  9. 8.2.2 Takeda Pharmaceutical Business Overview
  10. 8.2.3 Takeda Pharmaceutical Niraparib Preparations Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Niraparib Preparations Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Recent Developments
  13. 8.3 Janssen Biotech
  14. 8.3.1 Janssen Biotech Company Information
  15. 8.3.2 Janssen Biotech Business Overview
  16. 8.3.3 Janssen Biotech Niraparib Preparations Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Janssen Biotech Niraparib Preparations Product Portfolio
  18. 8.3.5 Janssen Biotech Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Niraparib Preparations Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GSK Niraparib Preparations Product Portfolio
  24. 8.4.5 GSK Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Niraparib Preparations Value Chain Analysis
  2. 9.1.1 Niraparib Preparations Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Niraparib Preparations Sales Mode & Process
  6. 9.2 Niraparib Preparations Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Niraparib Preparations Distributors
  9. 9.2.3 Niraparib Preparations Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst